Gail E Potter

9PUBLICATIONS
61CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Epidemiological modellingCardiology (incl. cardiovascular diseases)Preventative health careImplementation science and evaluation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 22, 2026
Antibiotic Prescribing Practices During the COVID-19 Pandemic: A Post-Hoc Analysis of the Adaptive COVID-19 Treatment Trial.

|Jun 03, 2025
The Choice of Viral Load End Point in Early Phase Trials of COVID-19 Treatments Aiming to Reduce 28-Day Hospitalization and/or Death.

Allyson Mateja, Eric Chu, Thomas A Murray

|Oct 10, 2024
Does Remdesivir Lower COVID-19 Mortality? A Subgroup Analysis of Hospitalized Adults Receiving Supplemental Oxygen.

Gail E Potter, Michael A Proschan

|Feb 26, 2024
A Risk Profile Using Simple Hematologic Parameters to Assess Benefits From Baricitinib in Patients Hospitalized With COVID-19: A Post Hoc Analysis of the Adaptive COVID-19 Treatment Trial-2.

Catharine I Paules, Jing Wang, Kay M Tomashek

|Dec 08, 2022
A randomized controlled trial showing safety and efficacy of a whole sporozoite vaccine against endemic malaria.

Sodiomon B Sirima, Alphonse Ouédraogo, Alfred B Tiono

|Nov 28, 2022
Temporal Improvements in COVID-19 Outcomes for Hospitalized Adults: A Post Hoc Observational Study of Remdesivir Group Participants in the Adaptive COVID-19 Treatment Trial.

Gail E Potter, Tyler Bonnett, Kevin Rubenstein

Pageof 2

Frequent Collaborators

2 joint publications

Tyler Bonnett

2 joint publications

Kevin Rubenstein

2 joint publications

Sarah B Doernberg

2 joint publications

David C Lye